These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12676148)

  • 1. Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats.
    Yang HY; Iadarola MJ
    Neuroscience; 2003; 118(1):179-87. PubMed ID: 12676148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide FF in the rat spinal cord during carrageenan inflammation.
    Kontinen VK; Aarnisalo AA; Idänpään-Heikkilä JJ; Panula P; Kalso E
    Peptides; 1997; 18(2):287-92. PubMed ID: 9149302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory role of neuropeptide FF system in nociception and opiate analgesia.
    Yang HY; Tao T; Iadarola MJ
    Neuropeptides; 2008 Feb; 42(1):1-18. PubMed ID: 17854890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide FF and modulation of pain.
    Panula P; Kalso E; Nieminen M; Kontinen VK; Brandt A; Pertovaara A
    Brain Res; 1999 Nov; 848(1-2):191-6. PubMed ID: 10612711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual localization of neuropeptide FF receptors in the rat dorsal horn.
    Gouardères C; Roumy M; Advokat C; Jhamandas K; Zajac JM
    Synapse; 2000 Jan; 35(1):45-52. PubMed ID: 10579807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model.
    Zhang R; Xu B; Zhang MN; Zhang T; Wang ZL; Zhao G; Zhao GH; Li N; Fang Q; Wang R
    Eur J Pharmacol; 2017 Oct; 813():122-129. PubMed ID: 28755985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception.
    Liu Q; Guan XM; Martin WJ; McDonald TP; Clements MK; Jiang Q; Zeng Z; Jacobson M; Williams DL; Yu H; Bomford D; Figueroa D; Mallee J; Wang R; Evans J; Gould R; Austin CP
    J Biol Chem; 2001 Oct; 276(40):36961-9. PubMed ID: 11481330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene.
    Nystedt JM; Lemberg K; Lintunen M; Mustonen K; Holma R; Kontinen VK; Kalso E; Panula P
    Neurobiol Dis; 2004 Jun; 16(1):254-62. PubMed ID: 15207282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG; Makriyannis A; Hohmann AG
    Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats.
    Huang J; Cai Q; Chen Y; Hong Y
    Brain Res; 2009 Dec; 1303():39-47. PubMed ID: 19782054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of intrathecally administered interleukin-1beta on carrageenan-induced hyperalgesia and spinal c-Fos expression in rats.
    Ji GC; Zhang YQ; Ma F; Cao XD; Wu GC
    Neurosci Lett; 2002 Aug; 328(2):137-40. PubMed ID: 12133574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory roles of the NPFF system in pain mechanisms at the spinal level.
    Yang HY; Iadarola MJ
    Peptides; 2006 May; 27(5):943-52. PubMed ID: 16443306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory potential of neuropeptide FF in vitro and in vivo.
    Sun YL; Zhang XY; Sun T; He N; Li JY; Zhuang Y; Zeng Q; Yu J; Fang Q; Wang R
    Peptides; 2013 Sep; 47():124-32. PubMed ID: 23856454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli.
    Vilim FS; Aarnisalo AA; Nieminen ML; Lintunen M; Karlstedt K; Kontinen VK; Kalso E; States B; Panula P; Ziff E
    Mol Pharmacol; 1999 May; 55(5):804-11. PubMed ID: 10220558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NPFFR2 leads to hyperalgesia through the spinal inflammatory mediator CGRP in mice.
    Lin YT; Liu HL; Day YJ; Chang CC; Hsu PH; Chen JC
    Exp Neurol; 2017 May; 291():62-73. PubMed ID: 28179153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
    Fang Q; Jiang TN; Li N; Han ZL; Wang R
    Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hyperalgesic effects of intrathecally administered neuropeptide W-23, and neuropeptide B, in tests of inflammatory pain in rats.
    Yamamoto T; Saito O; Shono K; Tanabe S
    Brain Res; 2005 May; 1045(1-2):97-106. PubMed ID: 15910767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide FF receptors have opposing modulatory effects on nociception.
    Lameh J; Bertozzi F; Kelly N; Jacobi PM; Nguyen D; Bajpai A; Gaubert G; Olsson R; Gardell LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):244-54. PubMed ID: 20354177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrageenan-induced changes in spinal nociception and its modulation by the brain stem.
    Pertovaara A; Hämäläinen MM; Kauppila T; Panula P
    Neuroreport; 1998 Jan; 9(2):351-5. PubMed ID: 9507982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
    Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
    Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.